Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
Suebsarn Ruksakulpiwat, Assistant Professor at Mahidol University, shared a post on LinkedIn about a recent articles he and his colleagues co-authored, adding:
”I am pleased to share that our latest study on the Stroke Risk Screening Scales (SRSS) has been accepted for publication in Vascular Health and Risk Management (Scopus Q1).
This study represents an important step in the SRSS development process, using a qualitative approach to pre-test and refine the scale before proceeding to further psychometric evaluation.
This work builds on our previous publications:
1. Ruksakulpiwat, S. (2021). Stroke risk screening scales (SRSS): identification of domain and item generation. Journal of Stroke and Cerebrovascular Diseases, 30(6), 105740.
2. Ruksakulpiwat S, Voss JG, Challa AK, Kudlowitz A. The evaluation of content relevance and representativeness of the new stroke risk screening scales. Clinical Nursing Research. 2024 Nov;33(8):591-602.
From domain and item generation through content validation, qualitative pre-testing, and psychometric evaluation, the SRSS continues to move toward the development of a comprehensive tool for stroke risk screening and prevention.
I am grateful to all collaborators and participants who have contributed to this ongoing work.”
Title 1: Stroke Risk Screening Scales (SRSS): Identification of Domain and Item Generation
Author: Suebsarn Ruksakulpiwat
Title 2: The Evaluation of Content Relevance and Representativeness of the New Stroke Risk Screening Scales
Authors: Suebsarn Ruksakulpiwat, Joachim G. Voss, Abhilash K Challa, Aaron Kudlowitz
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin
-
Aug 10, 2026, 15:47Edward Lee Carter: 61% of Patients on Reduced-Dose Apixaban Did Not Meet Label Criteria
-
Aug 10, 2026, 15:45Vrushali Lad: What Living With DVT Taught Me About Lifestyle and Movement
-
Aug 10, 2026, 15:42Wolfgang Miesbach: Cognitive Impairment in aPL-Positive Patients